Molecular mapping of the regenerative niche in a murine model of myocardial infarction

International Journal of Molecular Medicine

Volumn 29, Issue 3, 2012, Pages 479-484

  Alves, Gabriela Dornelles ^a   Pazzine, Mariana ^b   Gomes De Macedo Braga, Luisa Maria ^c   Irigoyen, Maria Cláudia ^b   De Angelis, Kátia ^b   Ikuta, Nilo ^a   Camassola, Melissa ^a   Nardi, Nance Beyer ^a  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Cardiology Institute   (Brazil)

Author keywords

Chemokines; Cytokines; Myocardial infarction; Regenerative niche; Stem cells

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCL2 CHEMOKINE; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SELECTION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXPERIMENTAL MODEL; GENE EXPRESSION PROFILING; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGENERATIVE MEDICINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION;

ADULT STEM CELLS; ANIMALS; CHEMOKINES; ECHOCARDIOGRAPHY; GENE EXPRESSION PROFILING; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; STEM CELL NICHE; TIME FACTORS;

EID: 84856189322     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.850     Document Type: Article

References (37)

1. Nardi NB: All the adult stem cells, where do they all come from? An external source for organ-specific stem cell pools. Med Hypotheses 64: 811-817, 2005.
2. Lodi D, Iannitti T and Palmieri B: Stem cells in clinical practice: applications and warnings. J Exp Clin Cancer Res 30: 9, 2011.
3. da Silva Meirelles L, Chagastelles PC and Nardi-NB: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119: 2204-2213, 2006.
4. Burt RK, Loh Y, Pearce W, et al: Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299: 925-936, 2008. (Pubitemid 351397068)
5. Illa-Bochaca I and Montuenga LM: The regenerative nidi of the locust midgut as a model to study epithelial cell differentiation from stem cells. J Exp Biol 209: 2215-2223, 2006. (Pubitemid 43987896)
6. Kirkpatrick JC, Fuchs S, Hermanns IM, Peters K and Unger-RE: Cell culture models of higher complexity in tissue engineering and regenerative medicine. Biomaterials 28: 5193-5198, 2007.
7. Frangogiannis NG: The immune system and cardiac repair. Pharmacol Res 58: 88-111, 2008.
8. Menasche P: Stem cell: where we stand. Dialog Cardiovasc Med 3: 123-133, 2003.
9. Mukherjee D, Lingam P, Chetcuti S, et-al: Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation 106: 1909-1912, 2002.
10. Meirelles Lda S, Fontes AM, Covas DT and Caplan-AI: Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20: 419-427, 2009.
11. Frangogiannis NG: Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res 53: 585-595, 2004.
12. Braunersreuther V, Mach F and Steffens S: The specific role of chemokines in atherosclerosis. Thromb Haemost 97: 714-721, 2007. (Pubitemid 46804314)
13. Vandervelde S, van Luyn MJ, Rozenbaum MH, Petersen-AH, Tio-RA and Harmsen MC: Stem cell-related cardiac gene expression early after murine myocardial infarction. Cardiovasc Res 73: 783-793, 2007. (Pubitemid 46237616)
14. Husberg C, Nygard S, Finsen AV, et al: Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. J Mol Cell Cardiol 45: 261-269, 2008.
15. Vilahur G, Juan-Babot O, Peña E, Oñate B, Casaní L and Badimon-L: Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. J Mol Cell Cardiol 50: 522-533, 2011.
16. de Macedo Braga LM, Lacchini S, et al: In situ delivery of bone marrow cells and mesenchymal stem cells improves cardiovascular function in hypertensive rats submitted to myocardial infarction. J Biomed Sci 15: 365-374, 2008.
17. Braga LM, Rosa K, Rodrigues B, et al: Systemic delivery of adult stem cells improves cardiac function in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 35: 113-119, 2008.
18. Nozawa E, Kanashiro RM, Murad N, et al: Performance of two-dimensional Doppler echocardiography for the assessment of infarct size and left ventricular function in rats. Braz J Med Biol Res 39: 687-695, 2006. (Pubitemid 43676619)
19. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3: 1101-1108, 2008. (Pubitemid 351818697)
20. Parissis JT, Adamapoulos S, Vanetsanou KF, Mentzikof-DG, Karas-SM and Kremastinos DT: Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in postinfarction left ventricular remodeling. J Interferon Cytokine Res 22: 223-229, 2002. (Pubitemid 34275490)
21. De Jager SC, Kraaijeveld AO, Grauss RW, et al: CCL3 (MIP-1α) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events. J Mol Cell Cardiol 45: 446-452, 2008.
22. Orn S, Breland UM, Mollnes TE, Manhenke K, Aukrust P and Ueland-T: The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction. Am J Cardiol 104: 1179-1183, 2009.
23. Schenk S, Mal N, Finan A, Zhang M, Kiedrowski M, Popovic-Z, Mccarthy-PM and Penn MS: Monocyte chemotatic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 25: 245-251, 2007. (Pubitemid 46052996)
24. Huang J, Zhang Z, Guo J, et al: Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res 106: 1753-1762, 2010.
25. Ardigo D, Assimes TL, Fortmann SP, et al: Advance Investigators. Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiol Genomics 31: 402-409, 2007. (Pubitemid 350127780)
26. Czarnowska E, Gajerska-Dzieciatkowska M, Kusmierski K, et-al: Expression of SDF-1-CXCR4 axis and an anti-remodelling affectiveness of foetal-liver stem cell transplantation in the infarcted rat heart. J Physiol Pharmacol 58: 729-744, 2007.
27. + cell homing to the infarcted heart. Tissue Eng 13: 2063-2071, 2007.
28. Lin HH, Chen YH, Chang PF, Lee YT, Yet SF and Chau-LY: Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. J Mol Cell Cardiol 45: 44-55, 2008.
29. Saxena A, Fish JE, White MD, et al: Stromal cell-derived factor-1α is cardioprotective after myocardial infarction. Circulation 117: 2224-2231, 2008.
30. Stich S, Haag M, Haupl T, Sezer O, Notter M, Kaps C, Sittinger-M and Ringe-J: Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12. Cell Tissue Res 336: 225-236, 2009.
31. Hiesinger W, Vinogradov SA, Atluri P, et al: Oxygen-dependent quenching of phosphorescence used to characterize improved myocardial oxygenation resulting from vasculogenic cytokine therapy: J Appl Physiol 110: 1460-1465, 2011.
32. Zhuang Y, Chen X, Xu M, Zhang LY and Xiang F: Chemokine stromal cell-derived factor 1/CXCL12 increases homing of mesenchymal stem cells to injured myocardium and neovascularization following myocardial infarction. Chin Med J 22: 183-187, 2009.
33. Zhang D, Huang W, Dai B, Zhao T, Ashraf A, Millard-RW, Ashraf-M and Wang Y: Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts. Am J Physiol Heart Circ Physiol 299: H1339-H1347, 2010.
34. Damas JK, Boullier A, Waehre T, et al: Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy. Arterioscler Thromb Vasc Biol 25: 2567-2572, 2005. (Pubitemid 43732280)
35. Deten A, Volz HC, Briest W and Zimmer HG: Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 55: 329-340, 2002. (Pubitemid 34775283)
36. Kirbis S, Breskvar UD, Sabovic M, Zupan I and Sinkovic-A: Inflammation markers in patients with coronary artery disease - comparison of intracoronary and systemic levels. Wien Klin Wochenschr 122: 31-34, 2010.
37. Rota M: SDF-1 axis and myocardial infarction. Am J Physiol Heart Circ Physiol 299: H1307-H1308, 2010.